Eversept Partners, LP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1697013 NEW YORK, NY

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$486,888

New position

Shares Held

427,095

first reported quarter

Ownership

0.154%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#36

of 169 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $209,186,993 across 4 Drug Manufacturers - Specialty & Generic names. AKBA ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	287,668	$155,867,152
2	LQDA	Liquidia Corp	428,652	$34,176,423
3	BCRX	Biocryst Pharmaceuticals Inc	1,865,653	$18,656,530
4	AKBA	Akebia Therapeutics, Inc. This page	427,095	$486,888

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$486,888	427,095	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.